MDM2 is overexpressed and regulated by the Eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus

Annals of Surgical Oncology

Volumn 18, Issue 5, 2011, Pages 1469-1477

  Hsu, Han Shui ^a,b   Chen, Hsin Wu ^a   Kao, Chia Li ^a   Wu, Min Li ^a   Li, Anna Fen Yau ^a   Cheng, Tzu Hao ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4E; MESSENGER RNA; PROTEIN MDM2; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CANCER PATIENT; CANCER TISSUE; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOPLASM; DISTANT METASTASIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE CONTROL; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOLECULAR MECHANICS; PREDICTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MDM2; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 79955790331     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1428-y     Document Type: Article

References (47)

1. B Culjkovic I Topisirovic KL Borden 2007 Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E Cell Cycle 6 65 69 17245113 10.4161/cc.6.1.3688 1:CAS:528: DC%2BD2sXnvFygtr4%3D (Pubitemid 46173883)
2. A De Benedetti JR Graff 2004 eIF-4E expression and its role in malignancies and metastases Oncogene 23 3189 3199 15094768 10.1038/sj.onc. 1207545 (Pubitemid 38638830)
3. A De Benedetti AL Harris 1999 eIF4E expression in tumors: its possible role in progression of malignancies Int J Biochem Cell Biol 31 59 72 10216944 10.1016/S1357-2725(98)00132-0 (Pubitemid 29094790)
4. IG Goodfellow LO Roberts 2008 Eukaryotic initiation factor 4E Int J Biochem Cell Biol 40 2675 2680 18069043 10.1016/j.biocel.2007.10.023 1:CAS:528:DC%2BD1cXhtFaisb7O
5. HG Wendel RL Silva A Malina, et al. 2007 Dissecting eIF4E action in tumorigenesis Genes Dev 21 3232 3237 18055695 10.1101/gad.1604407 1:CAS:528:DC%2BD2sXhsVOrsb7K (Pubitemid 350277750)
6. Hershey JWB, Miyamoto S. Translational Control and Cancer. Translational Control of Gene Expression. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2000.
7. Z Salehi F Mashayekhi 2006 Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer Clin Biochem 39 404 409 16375881 10.1016/j.clinbiochem.2005.11.007 1:CAS:528:DC%2BD28XjvVGisbc%3D
8. AC Gingras B Raught N Sonenberg 1999 eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation Annu Rev Biochem 68 913 963 10872469 10.1146/annurev.biochem.68.1.913 1:CAS:528: DyaK1MXlvFajtL4%3D (Pubitemid 29449212)
9. A Lazaris-Karatzas KS Montine N Sonenberg 1990 Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap Nature 345 544 547 2348862 10.1038/345544a0 1:CAS:528:DyaK3cXktlygsrg%3D (Pubitemid 20178912)
10. S Avdulov S Li V Michalek, et al. 2004 Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells Cancer Cell 5 553 563 15193258 10.1016/j.ccr.2004.05.024 1:CAS:528:DC%2BD2cXltlGgsL4%3D (Pubitemid 38748917)
11. NJ Moerke H Aktas H Chen, et al. 2007 Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G Cell 128 257 267 17254965 10.1016/j.cell.2006.11.046 1:CAS:528:DC%2BD2sXhsVOru7Y%3D (Pubitemid 46137991)
12. NK Gray M Wickens 1998 Control of translation initiation in animals Annu Rev Cell Dev Biol 14 399 458 9891789 10.1146/annurev.cellbio.14.1.399 1:CAS:528:DyaK1cXnvFyisrw%3D (Pubitemid 29001460)
13. N Sonenberg 2008 eIF4E, the mRNA cap-binding protein: from basic discovery to translational research Biochem Cell Biol 86 178 183 18443631 10.1139/O08-034 1:CAS:528:DC%2BD1cXlvVCqsL8%3D (Pubitemid 351536498)
14. TE Dever 2002 Gene-specific regulation by general translation factors Cell 108 545 556 11909525 10.1016/S0092-8674(02)00642-6 1:CAS:528: DC%2BD38XhvF2js78%3D (Pubitemid 34260879)
15. VK Rajasekhar A Viale ND Socci, et al. 2003 Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes Mol Cell 12 889 901 14580340 10.1016/S1097-2765(03) 00395-2 1:CAS:528:DC%2BD3sXovVKjtbg%3D (Pubitemid 37352782)
16. Y Mamane E Petroulakis Y Martineau, et al. 2007 Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation PLoS One 2 e242 17311107 10.1371/journal.pone.0000242
17. JM Stommel GM Wahl 2005 A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation Cell Cycle 4 411 417 15684615 10.4161/cc.4.3.1522 1:CAS:528:DC%2BD28XktlCrsQ%3D%3D (Pubitemid 41359726)
18. C Cordon-Cardo E Latres M Drobnjak, et al. 1994 Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas Cancer Res 54 794 799 8306343 1:CAS:528:DyaK2cXhs1Sgsb4%3D (Pubitemid 24068339)
19. FS Leach T Tokino P Meltzer, et al. 1993 p53 Mutation and MDM2 amplification in human soft tissue sarcomas Cancer Res 53 2231 2234 8387391 1:STN:280:DyaK3s3ltFCnsQ%3D%3D (Pubitemid 23156805)
20. M Higashiyama O Doi K Kodama, et al. 1997 MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation Br J Cancer 75 1302 1308 9155050 10.1038/bjc.1997.221 1:STN:280:DyaK2s3pvF2jsw%3D%3D (Pubitemid 27179820)
21. Q Xue T Sano K Kashiwabara T Oyama T Nakajima 2001 Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung Jpn J Cancer Res 92 285 292 11267938 1:CAS:528:DC%2BD3MXjs1Olsbc%3D (Pubitemid 32288290)
22. TH Cheng PK Hsu AF Li, et al. 2009 Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma J Cancer Res Clin Oncol 135 1577 1582 19488782 10.1007/s00432-009-0605-5 1:CAS:528: DC%2BD1MXhtFCjtbzM
23. S Arora R Mathew M Mathur TK Chattopadhayay R Ralhan 2001 Alterations in MDM2 expression in esophageal squamous cell carcinoma: relationship with p53 status Pathol Oncol Res 7 203 208 11692147 10.1007/BF03032350 1:CAS:528:DC%2BD3MXoslams7s%3D (Pubitemid 33716856)
24. I Shibagaki H Tanaka Y Shimada, et al. 1995 p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma Clin Cancer Res 1 769 773 9816044 1:CAS:528:DyaK2MXnt1Cgtbs%3D
25. C Capoulade B Bressac-de Paillerets I Lefrère, et al. 1998 Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells Oncogene 16 1603 1610 9569028 10.1038/sj.onc.1201702 1:CAS:528:DyaK1cXis1eju70%3D (Pubitemid 28159908)
26. JE Landers SL Cassel DL George 1997 Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein Cancer Res 57 3562 3568 9270029 1:CAS:528:DyaK2sXls1Sgsrg%3D (Pubitemid 27355508)
27. CL Kao HS Hsu HW Chen TH Cheng 2009 Rapamycin increases the p53/MDM2 protein ratio and p53-dependent apoptosis by translational inhibition of mdm2 in cancer cells Cancer Lett 286 250 259 19560264 10.1016/j.canlet.2009.05.031 1:CAS:528:DC%2BD1MXhsVWmu73F
28. L Xiong F Kou Y Yang J Wu 2007 A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop J Cell Biol 178 995 1007 17846171 10.1083/jcb.200703044 1:CAS:528:DC%2BD2sXhtVGjurjN (Pubitemid 47443322)
29. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York: Springer, 2002.
30. MC Lai WY Tarn 2004 Hypophosphorylated ASF/SF2 binds TAP and is present in messenger ribonucleoproteins J Biol Chem 279 31745 31749 15184380 10.1074/jbc.C400173200 1:CAS:528:DC%2BD2cXlslOrt7c%3D (Pubitemid 39037846)
31. B Culjkovic I Topisirovic L Skrabanek M Ruiz-Gutierrez KL Borden 2006 eIF4E is a central node of an RNA regulon that governs cellular proliferation J Cell Biol 175 415 426 17074885 10.1083/jcb.200607020 1:CAS:528: DC%2BD28XhtFyrt7rE (Pubitemid 44708066)
32. B Culjkovic I Topisirovic L Skrabanek M Ruiz-Gutierrez KL Borden 2005 eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3′ UTR J Cell Biol 169 245 256 15837800 10.1083/jcb.200501019 1:CAS:528: DC%2BD2MXjslartr4%3D (Pubitemid 40656563)
33. A Moumen S Patane A Porras R Dono F Maina 2007 Met acts on Mdm2 via mTOR to signal cell survival during development Development 134 1443 1451 17329361 10.1242/dev.02820 1:CAS:528:DC%2BD2sXlt1Oks7c%3D (Pubitemid 46706049)
34. M Wade GM Wahl 2009 Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry? Mol Cancer Res 7 1 11 19147532 10.1158/1541-7786.MCR-08-0423 1:CAS:528:DC%2BD1MXltV2ltg%3D%3D
35. J Momand D Jung S Wilczynski J Niland 1998 The MDM2 gene amplification database Nucleic Acids Res 26 3453 3459 9671804 10.1093/nar/26.15.3453 1:CAS:528:DyaK1cXltlKqsr4%3D (Pubitemid 28347214)
36. JD Oliner KW Kinzler PS Meltzer, et al. 1992 Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 358 80 83 1614537 10.1038/358080a0 1:CAS:528:DyaK3sXisFagsbs%3D
37. RJ Morgan PV Newcomb RH Hardwick D Alderson 1999 Amplification of cyclin D1 and MDM-2 in oesophageal carcinoma Eur J Surg Oncol 25 364 367 10419705 10.1053/ejso.1999.0658 1:STN:280:DyaK1MzltValtQ%3D%3D (Pubitemid 29364221)
38. A Esteve T Lehman W Jiang, et al. 1993 Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas Mol Carcinog 8 306 311 8280379 10.1002/mc.2940080414 1:STN:280:DyaK2c7gslCkug%3D%3D (Pubitemid 24033242)
39. T Ishizuka C Tanabe H Sakamoto, et al. 2002 Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH Biochem Biophys Res Commun 296 152 155 12147242 10.1016/S0006-291X(02)00836-7 1:CAS:528: DC%2BD38XlvVSitrk%3D (Pubitemid 35002070)
40. K Takahashi M Miyashita H Makino, et al. 2009 Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma Exp Mol Pathol 87 42 47 19124015 10.1016/j.yexmp.2008.11.013 1:CAS:528:DC%2BD1MXotFOrt7g%3D
41. P Taniere G Martel-Planche P Puttawibul, et al. 2000 TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in south Thailand Int J Cancer 88 223 227 11004672 10.1002/1097-0215(20001015)88: 2<223::AID-IJC12>3.0.CO;2-G 1:CAS:528:DC%2BD3cXntlynur8%3D
42. D Zhu L Wang C Zhang, et al. 1996 No evidence for the amplifications of MDM2 and C-myc genes involved in the genetic susceptibility to esophageal cancer in a high-risk area of north China Cancer Genet Cytogenet 89 184 185 8697432 10.1016/0165-4608(95)00367-3 1:STN:280:DyaK28zhvFKquw%3D%3D
43. X Jin E Turcott S Englehardt GJ Mize DR Morris 2003 The two upstream open reading frames of oncogene mdm2 have different translational regulatory properties J Biol Chem 278 25716 25721 12730202 10.1074/jbc.M300316200 1:CAS:528:DC%2BD3sXlt1Clsrg%3D (Pubitemid 36835327)
44. SN Jones AR Hancock H Vogel, et al. 1998 Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis Proc Natl Acad Sci U S A 95 15608 15612 9861017 10.1073/pnas.95.26.15608 1:CAS:528:DyaK1MXhvFejtQ%3D%3D (Pubitemid 29018747)
45. N Seki T Takasu K Mandai, et al. 2002 Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung Clin Cancer Res 8 3046 3053 12374671 1:CAS:528: DC%2BD38XosFKhsr8%3D (Pubitemid 35155013)
46. BD Li JS Gruner F Abreo, et al. 2002 Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome Ann Surg 235 732 738 11981220 10.1097/00000658-200205000-00016 (Pubitemid 34454162)
47. CN Chen FJ Hsieh YM Cheng PH Lee KJ Chang 2004 Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome J Surg Oncol 86 22 27 15048676 10.1002/jso.20037 1:CAS:528: DC%2BD2cXjslertr0%3D (Pubitemid 38490096)